The pharmaceutical industry has a proud record of creating value for society by reducing the individual, economic and social burden of disease. But if it is to continue to be a force for good in the world, radical changes are needed to the industry’s historic ways of doing business.
That was the key message of a speech by Chief Executive Officer David Brennan at a recent high-profile gathering of business leaders.
I am proud of my industry and what it has achieved. It will not be easy to maintain that same progress in the next fifty years; the world is a more complex and more challenging place. But you should not doubt our commitment to delivering sustainable value to our shareholders and to society as a whole.
| Title | Speaker | Date & Location |
|---|---|---|
| The Role of the Pharmaceutical Industry in Improving Global Health (PDF 133kb) | David Brennan | 30 September 2011, London |
| UN High-level Meeting on Non-communicable Diseases (PDF 103kb) | David Brennan | 19 September 2011, New York |
| IFPMA – British Consulate General Reception (PDF 104kb) | David Brennan | 19 September 2011, New York |
| The Challenge of NCDs in Africa (PDF 134kb) | David Brennan | 17 May 2011 |
| David Brennan Istanbul speech (PDF 136kb) | David Brennan | 04 May 2011, Istanbul |
| London Business School speech (PDF 172kb) | David Brennan | 22 November, London |
| IFPMA Assembly speech (PDF 132kb) | David Brennan | 10 November, London |
| Asia Business Leaders Conference - Engaging the Asian Future (PDF 123kb) | David Brennan | 13 October, London |
| Speech to the PDA/FDA Joint Regulatory Conference (PDF 153kb) | David Brennan | 13 September, Washington DC |